肠易激综合征的治疗进展  

Progress in the treatment of irritable bowel syndrome

作　　者：胡玥[1] 吕宾[1] HU Yue;LYU Bin(Department of Gastroenterology,First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310006,China)

机构地区：[1]浙江中医药大学附属第一医院消化科

出　　处：《中国实用内科杂志》2020年第2期105-110,共6页Chinese Journal of Practical Internal Medicine

摘　　要：肠易激综合征(irritable bowel syndrome,IBS)作为消化系统疾病中较为常见的功能性胃肠病,由于发病机制未明,临床上缺乏行之有效的治疗手段,其临床诊治一直以来是研究的热点和难点。而近年来,相关药物的研发及诊疗策略的更新,使得IBS的诊疗得到了进一步发展。文章就目前IBS的治疗进展做一论述,以期为IBS的临床诊治提供指导,使更多的IBS患者从中获益。Irritable bowel syndrome(IBS)is a common functional gastrointestinal disorder in digestive diseases.The pathogenesis of IBS is not completely understood and there is no clinically effective treatment.Thus,its clinical diagnosis and treatment have been hotspots and difficulties for researchers.In recent years,the development of drugs and the update of diagnosis and treatment strategies have contributed to the further progress in the diagnosis and treatment of IBS.Therefore,this article discusses the current progress in the diagnosis and treatment of IBS,in order to provide guidance and benefit more patients with IBS.

关 键 词：肠易激综合征 治疗 管理 

分 类 号：R574.4[医药卫生—消化系统]